NHS Alliance calls for better recognition of clinical pharmacist role in ‘high street pharmacy’

NHS Alliance calls for better recognition of clinical pharmacist role in ‘high street pharmacy’

June 29 2016 The NHS should support clinical pharmacist roles in community pharmacies as well as...

Generics manufacturers call for retention of European registration system, post referendum

Generics manufacturers call for retention of European registration system, post referendum

June 29 2016 Generics medicines manufacturers are calling for Britain to keep the current...

Naloxone guidance updated to include supply to children young people

Naloxone guidance updated to include supply to children young people

June 27 2016 Guidance on naloxone supply has been updated with advice about what to consider when...

Pharmacy contractors say reform programme timetable is ‘unacceptably tight’

Pharmacy contractors say reform programme timetable is ‘unacceptably tight’

June 22 2016 The organisation representing pharmacy owner associations has criticised the lack of...

Consultation on how the Falsified Medicines Directive should be implemented

Consultation on how the Falsified Medicines Directive should be implemented

June 22 2016 A four week consultation has commenced asking how the European Falsified Medicines...

  • NHS Alliance calls for better recognition of clinical pharmacist role in ‘high street pharmacy’

    NHS Alliance calls for better recognition of clinical pharmacist role in ‘high street pharmacy’

    Wednesday, 29 June 2016 11:46
  • Generics manufacturers call for retention of European registration system, post referendum

    Generics manufacturers call for retention of European registration system, post referendum

    Wednesday, 29 June 2016 11:37
  • Naloxone guidance updated to include supply to children young people

    Naloxone guidance updated to include supply to children young people

    Tuesday, 28 June 2016 13:48
  • Pharmacy contractors say reform programme timetable is ‘unacceptably tight’

    Pharmacy contractors say reform programme timetable is ‘unacceptably tight’

    Wednesday, 22 June 2016 14:27
  • Consultation on how the Falsified Medicines Directive should be implemented

    Consultation on how the Falsified Medicines Directive should be implemented

    Wednesday, 22 June 2016 14:16

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

medications 1June 22 2016

A four week consultation has commenced asking how the European Falsified Medicines Directive should be implemented in the UK.

The Directive was introduced in October 2015 and aims to prevent the entry of falsified medicines into the legal pharmaceutical supply chain. It sets out “obligations on pharmaceutical manufacturers and supply chain stakeholders to establish a pan-European system where the identification and the authentication of medicinal products is guaranteed by the end-to-end verification of all medicinal products bearing the safety features.”

The system requires greater traceability on medicines including packs to contain a unique identifier code so they can be tracked through the supply chain, and anti-tampering packaging. All medicines will have to comply with the regulations by 2018.

Medicines manufacturer and supplier organisations in the UK have now come together to consult on the proposed User Requirement Specifications (URS) for the UK Medicines Verification System (UKMVS). The URS describes how the system will work, centred on a European hub which will serve as the principle storage place for master data and will be the gateway for transmitting manufacturer data to the national systems. It will also be where data reconciliation is done, so that original and repackaged products can be tracked throughout the EU.

Manufacturers will submit package unique identifier codes to the European hub, and as the product is repackaged or shipped between countries by parallel importers, the data will be scanned at a each stage for verification at the Europe hub. It also means that packs can be ‘decommissioned’ (eg withdrawn or shipped out of the EU) and stock can be reconciled, or products affected by alerts can be traced across different countries.

National systems will be verification platforms that pharmacies or other registered parties such as wholesalers, self-dispensing doctors or hospital pharmacies can use to check a product’s ‘authenticity’. All data necessary to perform this and other relevant transactions will be stored in the respective National Systems.

The consultation is asking for views on the URS and in particular:

  • any discrepancies with the requirements of the Delegated Regulation (EU) 2016/161;
  • any concerns regarding the overall architecture of the EMVS and in particular the key tasks of the National System;
  • any disagreement with the Governing Principles;
  • any disagreement with the Design and Implementation Principles;
  • any critical gaps in the major functions or additional requirements as outlined;
  • any additional user requirements, specific to the needs of a UK verification system;
  • any priority ‘use cases’ not currently listed.

Members of the informal alliance, UK ESM FMD Partners, conducting the consultation are the ABPI (research-based pharmaceutical industry representatives), BAEPD (parallel distributor representatives), NPA and CCA (dispensing entity representatives) and HDA (wholesaler representatives).

Links:

BGMA announcement http://www.britishgenerics.co.uk/view-news/consultation-launched-on-implementing-the-falsified-medicines-directive-in-the-uk

Consultation documents https://app.citizenspace.com/ukmvo/consultation-on-the-ukmvs-urs

Legal & Policy News

June 29 2016 The NHS should support clinical pharmacist roles in community pharmacies as well as at GP practices, the New NHS Alliance has proposed.
December 7 2015 Pharmacists in Scotland have been asked to share their views on what politicians need to be made aware of ahead of the Scottish Parliament elections in 2016. The Royal Pharmaceutical Society...